Kerri Pryce

Neuropharmacologist. 🇯🇲 🇺🇸  Interested in neuroepigenetics, and the neurobiology of chronic pain and affective disorders. Postdoc @IcahnMountSinai 

[Kerri Pryce @KerriPryce]

@DeadlineDayLive Ra a 551ײiiu⅞

[Lasker Foundation @LaskerFDN]

Researchers discover that HDAC1 regulates opioid withdrawal. In a mouse model of chronic pain, treatment with HDAC inhibitors ⬇️ signs of opioid withdrawal, opening new avenues for chronic pain and opioid withdrawal management. @VannaZachariou @KerriPryce
https://t.co/xgWDliMsos

[Alex Serafini, PhD/MHA @ra_serafini]

(1/7) When I joined the @VannaZachariou Lab, the team was curious about whether we are really modeling what #chronic #pain patients might be going through in the current #opioid #epidemic?
https://t.co/aZhDc0TjCA

[Friedman Brain Institute @SinaiBrain]

PRESS RELEASE: A NEW STUDY by @KerriPryce
@ra_serafini @VannaZachariou, et al., published @NatureNeuro, identifies molecular pathways in emotional centers of the brain particularly affected by opioids in subjects experiencing #ChronicPain. Learn More👉https://t.co/vLXbRFe8iJ

[Eric Topol @EricTopol]

New, important #LongCovid report @ScienceTM: persistent pro-inflammatory biology
"These data highlight a molecular mechanism for persistent COVID-19 symptomatology and provide a small animal model to explore future therapeutics."
https://t.co/iLQ8dTw8BA @Justin_Frere @virusninja

[Justin Frere @Justin_Frere]

This project was a massive collaborative effort, and I am extraordinarily grateful to @ra_serafini, @KerriPryce, Marianna Zazhytska, @VannaZachariou, @LomvardasLab, @RobSchwartzLab, and all the other authors and individuals who made this work possible!

[Alex Serafini, PhD/MHA @ra_serafini]

@Justin_Frere @KerriPryce Had an awesome time on this project! Thanks for giving us the opportunity to contribute to such important work and for hosting crazy brainstorming sessions.

[Retina Technologies Inc. @rettech_inc]

Our new raise on StartEngine is NOW LIVE! If you or someone you know are ready to join a team and community of investors passionate about catching eye disease early, visit  https://t.co/VEyRqTZG5Q. To learn more about our mission, technologies, and team, visit our website!

[Benjamin tenOever @virusninja]

After 1.5yrs of studying #LongCOVID in both people and hamsters, we now can propose a molecular basis for how it develops. Amazing work by @Justin_Frere in collaboration with @ra_serafini @kerripryce @robschwartzlab @vannazachariou
@lomvardaslab et al.
https://t.co/cAKsBgZOtb

[Justin Frere @Justin_Frere]

I’m also extremely grateful to both @KerriPryce and @ra_serafini, who spent countless hours in a high biocontainment facility with me to carry this project to completion and provided invaluable expertise and support during this project. This wouldn't be possible without them

[Angeline J. Dukes, PhD @HeyDrDukes]

.@AustinAColey finally made it into a photo 😂😂

#BlackInNeuro at #ACNP2021 ✨

[University at Buffalo Pharmacology and Toxicology @UBPharmTox]

News coverage of the exciting research being done in the @Bhattacharjee__ lab; lead author @PowellRasheen; published in Nature Communications. Congrats! #analgesics #pain https://t.co/kXa8x9I4Sr

[Arin Bhattacharjee @Bhattacharjee__]

https://t.co/J28F2c6bCm #ChronicPain #biotech #opioidcrisis #opioids #Forbes #drugs

[Rasheen Powell, Ph.D. @PowellRasheen]

What a morning. A beautiful Bills win yesterday...and my thesis work has been published in Nature Communications! This couldn't have been possible without the help of @Bleed_Oil,@GarrettDSheehan ,@ultrav1ol3t13 , and @KerriPryce https://t.co/MidMV4A0nb

[Marta Filizola @martafilizola]

Final open access version of "A Promising Chemical Series of Positive Allosteric Modulators of the μ-Opioid Receptor that Enhance the Antinociceptive Efficacy of Opioids but not their Adverse Effects" now available online https://t.co/xnz6V1Y0AP

[Friedman Brain Institute @SinaiBrain]

NEW PUBLICATION by @KerriPryce, @VannaZachariou, @martafilizola, et al. CONGRATS!🎉
👉A Promising Chemical Series of Positive Allosteric Modulators of the μ-Opioid Receptor that Enhance the Antinociceptive Efficacy of Opioids but not their Adverse Effects https://t.co/Q8nvgfgRvA

[Science Translational Medicine @ScienceTM]

Experiments in mice and human neurons suggest the ion channel protein TRPC5 contributes to tactile and spontaneous #pain hypersensitivity after inflammation and nerve injury, according to @KateSadlerPhD, @Dr_CherylStucky and co at @MedicalCollege. https://t.co/OatWdD47ro

[Dr. Rajesh Khanna of the KhannaLabUF @KhannaLabUF]

#channels #chronicpain
Vertex has previously validated the potential role of NaV1.8 inhibitors with positive proof-of-concept results in a variety of pain conditions https://t.co/woPhhJ4VRV

Will this lead to a new drug for chronic pain?